Additional information
Off white Powder
1330076-52-2
ACI-190812
1-Hydroxy-4-(2-hydroxy-5-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)benzyl)-2-naphthoic acid
1-Hydroxy-4-[[2-hydroxy-5-[1-hydroxy-2-[[6-(4-phenylbutoxy)hexyl]amino]ethyl]phenyl]methyl]-2-naphthalenecarboxylic acid
NA
C36H43NO6
585.73
Ambient
2-8°C
Salmeterol xinafoate adduct impurity
Adrenergic bronchodilator





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)